Skip to Content
Skip to Search
Skip to Topics
Skip to Navigation
Government of Nova Scotia
gov.ns.ca
gov.ns.ca
Government of Nova Scotia
Nova Scotia, Canada
Search
Health and Wellness
Topics
Publications
Health Professionals
A-Z Index
Contact
Navigation
Home
About
Minister
Deputy Minister
Chief Public Health Officer
Contact Information
Corporate Reports
News
District Health Authorities
Hospitals
Public Health Offices
Services de santé
Programs and Services
Addiction Services
Do I need help?
I need help!
Where Do I Go For Help?
Alcohol
Gambling
Tobacco
Other Drugs
Cancer Drugs
Continuing Care
Long-term Care
Home care
Self Managed Care
Caregiver Benefit
Personal Alert Assistance Program
Adult Protection Services
Licensed Facilities
Fact Sheets & Forms
Continuing Care Careers
Contact
Continuing Care Strategy
The Vision
The Strategy
Long Term Care Beds
Peritoneal Dialysis
Frequently Asked Questions
Fact Sheets
Did you know?
eHealth
EHS
Family Physicians
Health Card (MSI)
Eligibility
Moving & Travel
Health Cards
Appeals
Frequently Asked Questions
Fact Sheets & Forms
Contact Information
Quality & Patient Safety
About Us
Advisory Committee
Health Services Emergency Management
Acts and Legislation
Outbreak Management
Natural Disasters and Severe Weather
Emergency Management Office
Links
Health Team Nova Scotia
Infection Prevention and Control
Mental Health
Vision & Values
Mental Health Priorities
Core Programs & Standards
Mental Health and Addictions Strategy
Adult Mental Health
Children & Youth Services
Seniors Mental Health
Depression Strategy
Consumer Involvement
MICA Awards
Involuntary Psychiatric Treatment Act
Patient Rights Advisor Services
Reports
First Aid for Mental Health
Finding Help
Links
Français
Nursing Strategy
Personal Health Information Legislation
Pharmacare Programs
Cancer Program
Community Services Pharmacare
Diabetes Program
Family Pharmacare
Seniors' Pharmacare
Benefits & Reimbursement
Exception Status Drugs
Expert Committees
Formulary
New Interchangeable Products
Pharmacare News Bulletins
Pharmacists' Guide
Contact Information
Physical Activity Sport and Recreation
Acts and Legislation
Policies
Regional Services
Funding, Tax Incentives and Grants
Courses and Training
Physical Activity
Outdoor Recreation
Active Transportation
Sport
Publications
Links
Contacts
Primary Health Care
Aboriginal Health
Building a Better Tomorrow Together
Chronic Disease Management
Collaborative Teams
Diversity and Social Inclusion
HealthLink 811
Health Literacy
Midwifery Initiative
Primary Health Care Information Management (PHIM) Program
Your Way to Wellness
Health Guidelines
Protection for Persons in Care Act
Public Health
Travel and Accommodation Assistance
Wait Times
Services de santé
Fournisseurs de soins de santé francophones
Health Care Professionals
Provincial Programs
Cancer Care Nova Scotia
Cardiovascular Health
About Us
Advisory Council
Publications
Activities
Data
Available Services
Resources
Contact
Diabetes Care Program of Nova Scotia
Legacy of Life
Nova Scotia Breast Screening Program
Nova Scotia Hearing and Speech Centers
Nova Scotia Provincial Blood Coordinating Program
The Canadian Perspective
FAQ's
For Health Care Professionals
Privacy
Contact
Nova Scotia Renal Program
Nova Scotia Reproductive Care Program
Employment
Physician Recruitment
Nursing Careers
Allied health
Province Employment Opportunities
Career Options
Nova Scotia Provincial Blood Coordinating Program
Administration of Blood and Blood Products
A Patient Guide to Blood & Blood Product Transfusion -
English
/
Français
Consent Form for Transfusion of Blood, Blood Components and/or Plasma Derivatives
Elements of Informed Consent for Blood and Blood Products
Guide to Blood Component and Blood Product Administration
Home Transfusion Guidelines
Refusal or Limited Consent Form for Transfusion of Blood and/or Blood Components, Plasma Derivatives
Toolkit for the Administration of Blood Components and Blood Products in Nova Scotia
Adverse Event Reporting
Adverse Transfusion Reactions - The 2007 Nova Scotia Report
Algorithm for Transfusion Reactions/Investigation of Adverse Transfusion Reactions
Provincial Standard for Hospitals to Report Adverse Reactions to Blood/Blood Components and Blood Products in Nova Scotia
Blood and Blood Products
Blood Guidelines Reference List
Factor Product Sheets - currently under revision
Intravenous Immunoglobulin (IVIG)
IVIG and SCIG Utilization in the Atlantic Provinces FY 2010/11
IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2009/10
IVIG Utilization in the Atlantic Provinces - Fiscal Year 2008/09
IVIG Administration Guidelines -
Adult
and
Pediatric
Gammagard Liquid Infusion Rate Table
Gammagard SD Infusion Rate Table
Gamunex-IGIVnex Infusion Rate Table
Privigen Infusion Table
Privigen Product information
Privigen Presentation
Massive Transfusion
Guidelines and Toolkit
Massive Transfusion Algorithm
Prothrombin Complex Concentrates (Octaplex® and Beriplex®P/N)
Utilization Guidelines for Prothrombin Complex Concentrates in Nova Scotia
National Advisory Committee (NAC) Recommendations for Use of Prothrombin Complex Concentrates in Canada
Octaplex Presentation for Nurses
Administration Guidelines for Prothrombin Complex Concentrate (octaplex)
Prothrombin Complex Concentrates Pre-Printed Order Form
Red Blood Cells
British Columbia Guidelines for Red Blood Cell Transfusion
Guideline for Washed Red Blood Cells in NS
NS RBC Discards Report Q1 2006 - Q2 2008
Subcutaneous Immunoglobulin (SCIG) Atlantic Guidelines for Subcutaneous Immune Globulin Home Administration Programs January 2012
Atlantic Guidelines for Subcutaneous Immune Globulin Home Administration Programs January 2012
National Advisory Committee (NAC) Recommendations for SCIG
rFVIIa (Niastase®)
National Advisory Committee (NAC) Recombinant factor rVIIa Transfusion Policy Framework
Nova Scotia Framework for recombinant Factor VIIa (Niastase®) Utilization
Request for Niastase
Blood Emergency Preparedness
Blood Shortage Simulation Report
Blood Emergency Response Team Terms Of Reference
The Provincial Blood Contingency Plan
National Plan for the Management of Shortages of labile Blood Components
Communication and Coordination
Communication and Coordination Survey Report - 2011
NSPBCP Annual Report FY 2009/10
Blood Matters November 4, 2011
Blood Warming A Hot Topic
Cryptocases from CDHA Files
Disclosure of Adverse Patient Safety Events and Harm
IVIG Associated Hemolysis
One Match National Public Cord Blood Bank
Patient Blood Management Exploring the Options
The Role of HLA
Transfusing_Appropriately
Blood Matters October 29, 2010
Autologous & Directed Donation
Autologous Donation: Insuring the benefits outweigh the risks
Identifying the Risks of Blood Transfusion
The Life Cycle of a Unit of Blood
Managing the Bleeding Patient
OneMatch Network Overview and Stem Cell/Bone Marrow Transplantation
Overview of Stem Cell Transplant
Rh Program of Nova Scotia
Subcutaneous Immune Globulin (SCIG) Therapy
Subcutaneous Immune Globulin
Newsletters
January 2012 Newsletter
July 2011 Newsletter
January 2011 Newsletter
July 2010 Newsletter
January 2010 Newsletter
July 2009 Newsletter
January 2009 Newsletter
July 2008 Newsletter
January 2008 Newsletter
July 2007 Newsletter
January 2007 Newsletter
July 2006 Newsletter
January 2006 Newsletter
July 2005 Newsletter
January 2005 Newsletter
July 2004 Newsletter
Hospital Letters
May 2, 2012
The Introduction of Octaplasma
March 7, 2012
NS Recommendations for Use of PCC
September 30, 2011
Washed Red Blood Cells
July 21, 2011
Phenotype Confirmatory Testing
Order Form
Brochures, Guidelines and Work Aids Order Form
Reporting Documents
Plasma Protein Products - Discards
Plasma Protein Products - Outdating Inventory
Crown copyright 2011, Province of Nova Scotia, all rights reserved.
Page last updated 2012-05-10.